Inve US ▾
MOMO

Altria Group (MO) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Consumer Staples· Apr 30, 2026

Source: earnings call transcript

Executive summary

Altria Group Q1 FY26 — Strong EPS Growth Driven by Smokeable Performance and on! PLUS Expansion

Altria delivered a strong first quarter, exceeding expectations with robust adjusted EPS growth, primarily driven by its resilient smokeable products segment and strategic pricing. The company reaffirmed its full-year EPS guidance, balancing strong initial performance with ongoing macroeconomic uncertainties and increased investments in its smoke-free portfolio, particularly the national expansion of on! PLUS and its regulatory pipeline. Management highlighted the moderation of cross-category movement from cigarettes to e-vapor and the continued pressure on price-sensitive consumers.

Highlights

5
  • Adjusted diluted EPS grew by 7.3% in Q1 FY26.

  • Smokeable products segment adjusted OCI grew by 6.3%, with margins expanding to 65.1%.

  • Marlboro expanded its share of the premium segment to 59.5%, up 0.1 share point year-over-year.

  • on! reported shipment volume grew nearly 18% to over 46 million cans in Q1 FY26.

  • Total PM USA retail share grew 0.4 share points year-over-year, demonstrating effective total portfolio strategy.

Concerns

4
  • on! and on! PLUS total oral tobacco category share declined 0.8 share points year-over-year to 7.8%.

  • Marlboro's overall retail share declined 1.4 share points year-over-year due to trade-down to discount segment.

  • Oral Tobacco Products segment adjusted OCI margins decreased 1.8 percentage points to 67.4% due to marketing investments and product mix.

  • Oral Tobacco Products segment volumes declined by approximately 8.5% when adjusted for trade inventory movements.

Guidance & targets

CategoryTargetConfidence
Full year adjusted diluted EPS
$5.56 to $5.72
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Smokeable Products
Strong financial performance driven by pricing and volume moderation. Marlboro strengthened its position in the premium segment, while Basic captured share in the discount segment.
Adjusted OCI margin: 65.1%Net price realization: 6.3%Reported domestic cigarette volume decline: 2.4%Adjusted domestic cigarette shipment volume decline: 4%Marlboro share of premium segment: 59.5%Marlboro share of premium segment YoY change: +0.1 share pointMarlboro share of premium segment sequential change: +0.2 share pointBasic retail share YoY growth: +2.4 share pointsBasic retail share sequential growth: +0.5 share pointsTotal PM USA retail share YoY growth: +0.4 share pointsTotal PM USA retail share sequential growth: +0.1 share pointCigar reported shipment volume decline: 0.2%
———6.3% adjusted OCI growth
Oral Tobacco Products
Delivered strong adjusted OCI despite margin pressure from marketing investments and product mix. on! showed strong shipment volume growth, but overall segment volume declined due to lower MST volumes and trade inventory impacts.
Adjusted OCI margin: 67.4%Adjusted OCI margin YoY change: -1.8 percentage pointsTotal segment reported shipment volume decline: 3.1%Adjusted segment volume decline: 8.5%on! reported shipment volume growth: 18%on! reported shipment volume: 46M+ canson! and on! PLUS total oral tobacco category share: 7.8%on! and on! PLUS total oral tobacco category share YoY change: -0.8 share pointson! and on! PLUS total oral tobacco category share sequential change: +0.2 share points
———$400M+ adjusted OCI

MO operating KPIs by quarter

MO operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Jun 2025 Q2 FY25 Dec 2025 Q4 FY25This call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Shipment volume on!
<44M reported shipment volume grew by more than 44% year-over-year to nearly 44 million cans in the fourth quarter. Source: earnings call transcript
39M+ reported shipment volume to over 39 million cans, representing 18% growth. Source: earnings call transcript
52.1M reported shipment volume increasing by 26.5% to 52.1 million cans versus the year ago period. Source: earnings call transcript
44M+ reported shipment volume to more than 44 million cans. Source: earnings call transcript
46M+ portfolio grew nearly 18% and to over 46 million cans in the first quarter, reflecting continued demand for on! Source: earnings call transcript
49.9M In the second quarter, on reported shipment volume was 49.9 million cans, down 4.2% versus the prior year due to trade inventory movements. Source: earnings call transcript
—
Share of oral tobacco category on!
8.9% performed well at retail, growing its share of the oral tobacco category by 2 share points year-over-year to 8.9% in the fourth quarter. Source: earnings call transcript
8.8% continued its momentum at retail, expanding its share of the oral tobacco category to 8.8%, an increase of 1.8 share points versus the prior year and 0.10 share points sequentially. Source: earnings call transcript
8.7% on!'s retail share of the total oral tobacco category was 8.7%, an increase of 0.7 share points versus the prior year. Source: earnings call transcript
7.7% on!'s retail share of the total oral tobacco category was 7.7% for the fourth quarter and 8.2% for the full year. Source: earnings call transcript
—
8.6% In the second quarter, on retail share reached 8.6%, up 0.8 share points sequentially and 0.3 share points year-over-year, driven by the introduction of on PLUS. Source: earnings call transcript
—
Share of premium segment Marlboro
59.4% Within the highly profitable premium segment, Marlboro expanded its share of premium to 59.4% for the fourth quarter, an increase of 0.1 share point year-over-year and sequentially. Source: earnings call transcript
59.3% In the first quarter, Marlboro expanded its share of the premium segment by 0.1 share point to 59.3% while other competitive brands ceded share. Source: earnings call transcript
—
59.2% In the premium segment, competitive dynamics during the fourth quarter contributed to Marlboro's share premium decreasing 0.1 share points to 59.2%. Source: earnings call transcript
59.5% In the first quarter, Marlboro expanded its share of the premium segment to 59.5%, up 0.1 share point versus the prior year and 0.2 share points sequentially. Source: earnings call transcript
59.6% In the second quarter, Marlboro's share premium was 59.6%, unchanged versus the prior year and up one-tenth sequentially. Source: earnings call transcript
+0.1 pt
Stores on! PLUS————
~100K And at the end of the first quarter, it was available in approximately 100,000 stores, representing 85% of nicotine pouch category volume. Source: earnings call transcript
120K In smoke-free, Helix expanded on PLUS to 120,000 stores nationwide. Source: earnings call transcript
—

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Product announcements

ProductTypeDetails
Marlboro Cowboy Cutexpansion

Risks & headwinds

Macroeconomic environment and consumer pressure Ongoing

Elevated everyday expenses and higher gas prices later in the quarter continued to weigh on discretionary income among more price-sensitive adult smokers.

Mitigation:PM USA's total portfolio strategy (Marlboro, Basic, Cowboy Cut) to address trade-down dynamics; revenue growth management tools.

Prevalence of illicit flavored disposable e-vapor products Ongoing

Approximately 70% of e-vapor volume is illicit flavor disposables.

Mitigation:Increased enforcement activity; pushing FDA for more efficient and predictable authorization process for compliant products.

Regulatory constraints on e-vapor products Ongoing

Limited number of FDA-authorized products.

Mitigation:Advocating for a more efficient and predictable FDA authorization process that supports responsible innovation.

Competitive environment in oral tobacco Q1 FY26

on! and on! PLUS together represented 7.8% of the total oral tobacco category, down 0.8 share points year-over-year.

Mitigation:National expansion of on! PLUS, new retail trade program to increase visibility and secure incremental fixture space, marketing efforts.

Q&A highlights

Why was Q1 stronger than expected, and why wasn't guidance raised or narrowed given the strong start?

Q1 strength was due to stronger volume performance in smokeable, driven by moderation in cross-category movement. Guidance was reaffirmed due to macroeconomic uncertainty, rising gas prices, and potential short-term nature of tax refund benefits. Growth is now expected to be more balanced between H1 and H2.

“We thought it was prudent to reaffirm guidance. We're a quarter into the year. Obviously, the macroeconomic environment remains challenging and uncertain.”

asked by Mirza Faham Baig · answered by Salvatore Mancuso

2 min read 6 chapters

Detailed narrative

Smokeable Products Performance

The smokeable products segment delivered strong financial performance with adjusted OCI growth of 6.3% and adjusted OCI margins expanding to 65.1%. This was supported by solid net price realization of 6.3%. Domestic cigarette volumes declined by 2.4% reported, or 4% adjusted for trade inventory, showing moderation in decline.

Marlboro strengthened its premium segment share to 59.5%, up 0.1 share point year-over-year, while Basic captured share in the discount segment, contributing to a 0.4 share point increase in total PM USA retail share year-over-year.

on! PLUS National Expansion and Regulatory Efforts

on! PLUS began nationwide shipping in March and is now available in approximately 100,000 stores, covering 85% of nicotine pouch category volume. It is the first product authorized under the FDA's pilot program for streamlining PMTA reviews. Altria has submitted applications for 6 additional on! PLUS varieties across 3 nicotine strengths, believing the science supports authorization within the 180-day statutory timeline.

E-Vapor Category Dynamics and Enforcement

The e-vapor category is showing signs of moderation in illicit flavored disposable product growth, attributed to increased enforcement activity and supply disruption. The estimated number of adult vapers remained stable at 20.5 million, with a modest decline in disposable e-vapor consumers. Altria sees a clear pathway to a compliant legal marketplace through efficient FDA authorization and sustained enforcement.

Macroeconomic Headwinds and Consumer Behavior

Elevated everyday expenses and higher gas prices continue to weigh on discretionary income for price-sensitive adult smokers, driving growth in the discount cigarette segment. While higher-than-normal tax refunds provided some short-term relief, the company is closely monitoring consumer economic conditions. Altria's total portfolio strategy, including Basic and the upcoming Cowboy Cut, aims to manage these trade-down dynamics.

Oral Tobacco Products Segment

The oral tobacco products segment delivered over $400 million in adjusted OCI, with margins at 67.4%, down 1.8 percentage points due to Helix marketing investments and product mix. Total segment reported shipment volume decreased 3.1%, with on! growth offset by lower MST volumes. Adjusted for trade inventory, segment volumes declined approximately 8.5%.

Capital Allocation and Balance Sheet

Altria returned approximately $1.8 billion in dividends and repurchased 4.5 million shares for $280 million in Q1. The company retired over $1 billion of debt, maintaining a strong debt-to-EBITDA ratio of 1.9x, in line with its target.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.